Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8546150rdf:typepubmed:Citationlld:pubmed
pubmed-article:8546150lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:8546150lifeskim:mentionsumls-concept:C1556084lld:lifeskim
pubmed-article:8546150lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8546150lifeskim:mentionsumls-concept:C1705387lld:lifeskim
pubmed-article:8546150lifeskim:mentionsumls-concept:C1708726lld:lifeskim
pubmed-article:8546150lifeskim:mentionsumls-concept:C0752121lld:lifeskim
pubmed-article:8546150lifeskim:mentionsumls-concept:C1425979lld:lifeskim
pubmed-article:8546150lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:8546150lifeskim:mentionsumls-concept:C0053776lld:lifeskim
pubmed-article:8546150pubmed:issue5lld:pubmed
pubmed-article:8546150pubmed:dateCreated1996-2-13lld:pubmed
pubmed-article:8546150pubmed:abstractTextAutosomal dominant cerebellar ataxias (ADCA) of type I, a group of clinically heterogeneous neurodegenerative disorders, are known to be genetically heterogeneous since a second locus for ADCA type I (SCA2) has been identified on the long arm of chromosome 12. Linkage analysis was performed in 7 French ADCA type I families in order to estimate its frequency. We analysed 121 individuals, 39 of whom were affected. In 6 families, the SCA2 candidate interval, spanning 12.8 cM, was excluded by bi- and multipoint analysis. In one family (SAL-315), however, the maximal positive lod score reached 2.03 at the D12S79 locus. A posterior probability of 94% in favor of linkage to SCA2 was calculated by homogeneity analysis. The clinical profile of this family was similar to that of previously described SCA1 and non-SCA1 families, except that dementia was observed in 2 out of 6 patients. This may be a clinical idiosyncrasy in this family and was insufficient for a genotype-phenotype correlation.lld:pubmed
pubmed-article:8546150pubmed:languageenglld:pubmed
pubmed-article:8546150pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8546150pubmed:citationSubsetIMlld:pubmed
pubmed-article:8546150pubmed:statusMEDLINElld:pubmed
pubmed-article:8546150pubmed:monthOctlld:pubmed
pubmed-article:8546150pubmed:issn0148-7299lld:pubmed
pubmed-article:8546150pubmed:authorpubmed-author:AgidYYlld:pubmed
pubmed-article:8546150pubmed:authorpubmed-author:PenetCClld:pubmed
pubmed-article:8546150pubmed:authorpubmed-author:DürrAAlld:pubmed
pubmed-article:8546150pubmed:authorpubmed-author:BriceAAlld:pubmed
pubmed-article:8546150pubmed:authorpubmed-author:ChneiweissHHlld:pubmed
pubmed-article:8546150pubmed:authorpubmed-author:StevaninGGlld:pubmed
pubmed-article:8546150pubmed:authorpubmed-author:CancelGGlld:pubmed
pubmed-article:8546150pubmed:authorpubmed-author:PothinYYlld:pubmed
pubmed-article:8546150pubmed:issnTypePrintlld:pubmed
pubmed-article:8546150pubmed:day9lld:pubmed
pubmed-article:8546150pubmed:volume60lld:pubmed
pubmed-article:8546150pubmed:ownerNLMlld:pubmed
pubmed-article:8546150pubmed:authorsCompleteYlld:pubmed
pubmed-article:8546150pubmed:pagination382-5lld:pubmed
pubmed-article:8546150pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:meshHeadingpubmed-meshheading:8546150-...lld:pubmed
pubmed-article:8546150pubmed:year1995lld:pubmed
pubmed-article:8546150pubmed:articleTitleSCA2 is not a major locus for ADCA type I in French families.lld:pubmed
pubmed-article:8546150pubmed:affiliationINSERM U289, Hôpital de la Salpêtrière, Paris, France.lld:pubmed
pubmed-article:8546150pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8546150pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8546150lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8546150lld:pubmed